Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer.

Tanese K, Nakamura Y, Hirai I, Funakoshi T.

Front Med (Lausanne). 2019 Jul 10;6:160. doi: 10.3389/fmed.2019.00160. eCollection 2019. Review.

2.

Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab.

Muto Y, Kitano S, Tsutsumida A, Namikawa K, Takahashi A, Nakamura Y, Yamanaka T, Yamamoto N, Yamazaki N.

J Dermatol. 2019 Jun;46(6):498-506. doi: 10.1111/1346-8138.14865. Epub 2019 Apr 4.

PMID:
30945333
3.

Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.

Hirai I, Tanese K, Nakamura Y, Ishii M, Kawakami Y, Funakoshi T.

Oncologist. 2019 Jun;24(6):e394-e396. doi: 10.1634/theoncologist.2018-0856. Epub 2019 Mar 7.

PMID:
30846514
4.

Successful control of adrenal metastasis with transcatheter arterial chemoembolization in metastatic melanoma patient undergoing treatment with immune checkpoint inhibitor.

Tahara U, Tanese K, Nakamura Y, Hirai I, Amagai M, Oguro S, Funakoshi T.

J Dermatol. 2019 Aug;46(8):e276-e278. doi: 10.1111/1346-8138.14835. Epub 2019 Mar 5. No abstract available.

PMID:
30835875
5.

The Nondual Awareness Dimensional Assessment (NADA): New tools to assess nondual traits and states of consciousness occurring within and beyond the context of meditation.

Hanley AW, Nakamura Y, Garland EL.

Psychol Assess. 2018 Dec;30(12):1625-1639. doi: 10.1037/pas0000615. Epub 2018 Jul 30.

PMID:
30058824
6.

Carboplatin and epirubicin combination therapy for advanced malignant epithelial skin tumors: Retrospective study of six patients.

Nakamura Y, Tanese K, Hirai I, Kawakami Y, Funakoshi T.

J Dermatol. 2018 Jul;45(7):874-875. doi: 10.1111/1346-8138.14328. No abstract available.

PMID:
29971836
7.

Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse.

Garland EL, Hanley AW, Bedford CE, Zubieta JK, Howard MO, Nakamura Y, Donaldson GW, Froeliger B.

J Addict Dis. 2018 Jan-Jun;37(1-2):14-22. doi: 10.1080/10550887.2018.1459148. Epub 2018 Jun 4.

PMID:
29863439
8.

Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.

Hirai I, Tanese K, Nakamura Y, Otsuka A, Fujisawa Y, Yamamoto Y, Hata H, Fujimura T, Matsushita S, Yoshino K, Kameyama K, Amagai M, Funakoshi T.

Med Oncol. 2018 May 9;35(6):92. doi: 10.1007/s12032-018-1154-z.

PMID:
29744813
9.

Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task.

Garland EL, Bryan CJ, Kreighbaum L, Nakamura Y, Howard MO, Froeliger B.

Drug Alcohol Depend. 2018 Jun 1;187:13-21. doi: 10.1016/j.drugalcdep.2018.02.014. Epub 2018 Mar 27.

PMID:
29626741
10.

Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan.

Tanaka N, Yabe D, Murotani K, Ueno S, Kuwata H, Hamamoto Y, Kurose T, Takahashi N, Akashi T, Matsuoka T, Osonoi T, Minami M, Shimono D, Seino Y; Positive SMBG Study Group Investigators.

J Diabetes Investig. 2018 Sep;9(5):1203-1211. doi: 10.1111/jdi.12827. Epub 2018 Apr 1.

11.

Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis.

Yamagami J, Nakamura Y, Nagao K, Funakoshi T, Takahashi H, Tanikawa A, Hachiya T, Yamamoto T, Ishida-Yamamoto A, Tanaka T, Fujimoto N, Nishigori C, Yoshida T, Ishii N, Hashimoto T, Amagai M.

J Invest Dermatol. 2018 Jul;138(7):1473-1480. doi: 10.1016/j.jid.2017.12.035. Epub 2018 Feb 2.

12.

Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Uchi H, Fujimura T, Matsushita S, Hata H, Okuhira H, Tanaka R, Nagai K, Ishida Y, Nakamura Y, Furudate S, Yamamura K, Imafuku K, Yamamoto Y.

J Dermatol Sci. 2018 Jan;89(1):60-66. doi: 10.1016/j.jdermsci.2017.10.009. Epub 2017 Oct 25.

PMID:
29079332
13.

Rapidly developed BRAF inhibitor-induced verrucous keratosis.

Nakamura Y, Mori T, Takae Y, Tsutsumida A, Takahashi A, Namikawa K, Hirai I, Yamazaki N.

J Dermatol. 2017 Nov;44(11):e274-e275. doi: 10.1111/1346-8138.13962. Epub 2017 Jul 22. No abstract available.

PMID:
28734005
14.

Randomized Controlled Trial of Brief Mindfulness Training and Hypnotic Suggestion for Acute Pain Relief in the Hospital Setting.

Garland EL, Baker AK, Larsen P, Riquino MR, Priddy SE, Thomas E, Hanley AW, Galbraith P, Wanner N, Nakamura Y.

J Gen Intern Med. 2017 Oct;32(10):1106-1113. doi: 10.1007/s11606-017-4116-9. Epub 2017 Jul 12.

15.

Investigating Clinical Benefits of a Novel Sleep-Focused Mind-Body Program on Gulf War Illness Symptoms: A Randomized Controlled Trial.

Nakamura Y, Lipschitz DL, Donaldson GW, Kida Y, Williams SL, Landward R, Glover DW, West G, Tuteja AK.

Psychosom Med. 2017 Jul/Aug;79(6):706-718. doi: 10.1097/PSY.0000000000000469.

PMID:
28406803
16.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.

Fukuda K, Funakoshi T, Sakurai T, Nakamura Y, Mori M, Tanese K, Tanikawa A, Taguchi J, Fujita T, Okamoto M, Amagai M, Kawakami Y.

Melanoma Res. 2017 Aug;27(4):326-334. doi: 10.1097/CMR.0000000000000342.

PMID:
28263240
17.

Nanocuvette: A Functional Ultrathin Liquid Container for Transmission Electron Microscopy.

Wadell C, Inagaki S, Nakamura T, Shi J, Nakamura Y, Sannomiya T.

ACS Nano. 2017 Feb 28;11(2):1264-1272. doi: 10.1021/acsnano.6b05007. Epub 2017 Feb 1.

PMID:
28135067
18.

Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse.

Garland EL, Bryan CJ, Nakamura Y, Froeliger B, Howard MO.

Psychopharmacology (Berl). 2017 Feb;234(4):621-629. doi: 10.1007/s00213-016-4494-4. Epub 2016 Dec 8.

19.

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy.

Nakamura Y, Kitano S, Takahashi A, Tsutsumida A, Namikawa K, Tanese K, Abe T, Funakoshi T, Yamamoto N, Amagai M, Yamazaki N.

Oncotarget. 2016 Nov 22;7(47):77404-77415. doi: 10.18632/oncotarget.12677.

20.

Successful treatment of widespread chronic gluteal hidradenitis suppurativa with combination of recycled skin graft and negative-pressure wound therapy.

Kinoshita-Ise M, Nakamura Y, Kumagai Y, Kubo A, Nagao K, Funakoshi T.

J Dermatol. 2017 Aug;44(8):973-975. doi: 10.1111/1346-8138.13583. Epub 2016 Sep 21. No abstract available.

PMID:
27651126

Supplemental Content

Loading ...
Support Center